| Moderna Switzerland GmbH - mNEXSPIKE 0.05 mg/mL, Injektionsdispersion | | 70272 | | 01 | | mNEXSPIKE 0.05 mg/mL | | Injektionsdispersion | | J07BN01 | | Covid-19, Rna-Based Vaccine | | 03.08.2026 | | |
| | Composition | | Suspension: SARS-CoV-2 XBB.1.5 mRNA 0.05 mg/ml, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, saccharum, aqua ad iniectabile, 1 ml corresp.. | | Packungsbestandteile | | | | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | | | B | | Oui | | 002 | 10 | | | B | | Oui |
|
|
